Company intelligence / Profile preview

Caperian

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Caperian is a longevity-focused biotechnology company that provides a platform for measuring and managing biological age and healthspan. Founded by a team of world-leading geroscience experts, the company utilizes advanced proteomics and artificial intelligence to analyze thousands of proteins in the blood to determine an individual's rate of aging. Their platform provides actionable insights and personalized interventions designed to delay the onset of age-related diseases and extend healthy life. By translating complex biological data into a Healthspan Score, Caperian aims to empower users and clinicians to monitor the effectiveness of longevity interventions in real-time.

Therapeutic areas: Other
Modalities: DiagnosticsProteomicsDigital Health
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Caperian.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Caperian.

Explore the full profile